NO20055002L - Benzol[1,2,5]tiadiazolforbindelser - Google Patents

Benzol[1,2,5]tiadiazolforbindelser

Info

Publication number
NO20055002L
NO20055002L NO20055002A NO20055002A NO20055002L NO 20055002 L NO20055002 L NO 20055002L NO 20055002 A NO20055002 A NO 20055002A NO 20055002 A NO20055002 A NO 20055002A NO 20055002 L NO20055002 L NO 20055002L
Authority
NO
Norway
Prior art keywords
benzo
thiadiazole
cck2
amidophenylsulfanylamino
treatment
Prior art date
Application number
NO20055002A
Other languages
English (en)
Other versions
NO20055002D0 (no
Inventor
Nigel P Shankley
Brett Allison
Laura C Mcatee
Victor K Phuong
Michal H Rabinowitz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20055002D0 publication Critical patent/NO20055002D0/no
Publication of NO20055002L publication Critical patent/NO20055002L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Det beskrives visse amidofenyl-sulfanylamino-benzo[l,2,5]tiadiazolforbindelser som CCK2 modulatorer som kan benyttes ved behandling av CCK2 medierte sykdommer.
NO20055002A 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser NO20055002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45863803P 2003-03-28 2003-03-28
PCT/US2004/009589 WO2005012275A2 (en) 2003-03-28 2004-03-26 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators

Publications (2)

Publication Number Publication Date
NO20055002D0 NO20055002D0 (no) 2005-10-27
NO20055002L true NO20055002L (no) 2005-12-14

Family

ID=34115280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055002A NO20055002L (no) 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser

Country Status (20)

Country Link
US (2) US7241759B2 (no)
EP (1) EP1675837A2 (no)
JP (1) JP2006528241A (no)
KR (1) KR20050119666A (no)
CN (1) CN1829704A (no)
AU (1) AU2004261547A1 (no)
BR (1) BRPI0408899A (no)
CA (1) CA2520546A1 (no)
CO (1) CO5700819A2 (no)
CR (1) CR8009A (no)
EC (1) ECSP056057A (no)
IS (1) IS8042A (no)
MX (1) MXPA05010484A (no)
NO (1) NO20055002L (no)
NZ (1) NZ542491A (no)
RS (1) RS20050733A (no)
RU (1) RU2005133206A (no)
UA (1) UA82872C2 (no)
WO (1) WO2005012275A2 (no)
ZA (1) ZA200508732B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
AU2005289887A1 (en) 2004-09-24 2006-04-06 Janssen Pharmaceutica, N.V. Sulfonamide compounds
US7599588B2 (en) * 2005-11-22 2009-10-06 Vascular Imaging Corporation Optical imaging probe connector
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
WO2008124518A1 (en) * 2007-04-03 2008-10-16 Janssen Pharmaceutica N.V. Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
EP2053052A1 (en) * 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
MX2012000256A (es) * 2009-06-29 2012-04-19 Agios Pharmaceuticals Inc Compuestos terapeuticos y composiciones.
RU2532492C1 (ru) * 2013-01-28 2014-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ эндоскопического лечения гастродуоденальных язв
EP3071206B1 (en) 2013-11-22 2021-02-17 CL Biosciences LLC Gastrin antagonists (eg yf476, netazepide) for treatment and prevention of osteoporosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703995B1 (fr) 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
ES2206754T3 (es) 1996-12-10 2004-05-16 Zeria Pharmaceutical Co., Ltd. Derivados de 1,5 - benzodiazepina.
WO2000078145A1 (en) * 1999-06-24 2000-12-28 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
GB0028702D0 (en) * 2000-11-24 2001-01-10 Novartis Ag Organic compounds
EP1385841A4 (en) 2001-05-07 2005-03-02 Smithkline Beecham Corp SULPHONAMIDES
ITTO20020674A1 (it) 2002-07-26 2004-01-26 Rotta Research Lab Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico

Also Published As

Publication number Publication date
RU2005133206A (ru) 2006-05-10
NO20055002D0 (no) 2005-10-27
US7241759B2 (en) 2007-07-10
WO2005012275A3 (en) 2006-05-11
ECSP056057A (es) 2006-01-27
CR8009A (es) 2008-09-10
UA82872C2 (en) 2008-05-26
AU2004261547A1 (en) 2005-02-10
NZ542491A (en) 2009-04-30
CO5700819A2 (es) 2006-11-30
US20040224983A1 (en) 2004-11-11
ZA200508732B (en) 2007-04-25
CA2520546A1 (en) 2005-02-10
CN1829704A (zh) 2006-09-06
MXPA05010484A (es) 2006-03-10
JP2006528241A (ja) 2006-12-14
US7550492B2 (en) 2009-06-23
BRPI0408899A (pt) 2006-04-18
RS20050733A (en) 2007-06-04
EP1675837A2 (en) 2006-07-05
WO2005012275A2 (en) 2005-02-10
IS8042A (is) 2005-09-23
US20070276016A1 (en) 2007-11-29
KR20050119666A (ko) 2005-12-21

Similar Documents

Publication Publication Date Title
NO20061122L (no) 2-(Quinoksalin-5-ylsuflonylamino)-benzamid forbindelser som CCK2 modulatorer
NO20055002L (no) Benzol[1,2,5]tiadiazolforbindelser
NO20072092L (no) Sulfonamidforbindelser
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
DE60224189D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
RS93604A (en) Substituted phenylacetamides and their use as glucokinase activators
EP2182063A3 (en) Modulation of EIF4E expression
YU17402A (sh) Nova spiroheterociklična jedinjenja upotrebljiva kao reverzibilni inhibitori cisteinskih proteaza
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
TW200745004A (en) Novel compounds, their preparation and use
WO2006072458A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
HK1068274A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
NO20031648L (no) Farmasöytiske lösninger av modafinilforbindelser
CA2474510A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
WO2005035537A3 (en) Substituted tricyclic heterocycles and their uses
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
AU2003903242A0 (en) Process for the treatment of wood
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
WO2004098522A3 (en) Gemini vitamin d3 compounds and methods of use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application